Claritev Return on Tangible Equity 2019-2024 | CTEV

Current and historical return on tangible equity values for Claritev (CTEV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Claritev Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $-1.65B $-4.55B 35.77%
2024-09-30 $-1.54B $-4.56B 33.07%
2024-06-30 $-1.17B $-4.61B 24.87%
2024-03-31 $-0.63B $-4.69B 13.21%
2023-12-31 $-0.09B $-4.75B 1.90%
2023-09-30 $-0.71B $-4.80B 14.72%
2023-06-30 $-0.67B $-4.87B 13.70%
2023-03-31 $-0.62B $-4.77B 12.54%
2022-12-31 $-0.57B $-4.86B 11.41%
2022-09-30 $0.10B $-4.96B -2.01%
2022-06-30 $0.16B $-5.07B -3.08%
2022-03-31 $0.10B $-5.17B -1.87%
2021-12-31 $0.10B $-5.30B -1.88%
2021-09-30 $-0.10B $-5.38B 1.77%
2021-06-30 $-0.46B $-5.49B 12.12%
2021-03-31 $-0.47B $-5.53B 21.68%
2020-12-31 $-0.52B $-5.28B 99.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.450B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.35
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.148B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.042B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00